Docking and Linking of Fragments to Discover Jumonji Histone Demethylase Inhibitors.
Korczynska, M., Le, D.D., Younger, N., Gregori-Puigjane, E., Tumber, A., Krojer, T., Velupillai, S., Gileadi, C., Nowak, R.P., Iwasa, E., Pollock, S.B., Ortiz Torres, I., Oppermann, U., Shoichet, B.K., Fujimori, D.G.(2016) J Med Chem 59: 1580
- PubMed: 26699912 
- DOI: 10.1021/acs.jmedchem.5b01527
- Primary Citation of Related Structures:  
5A7N, 5A7O, 5A7P, 5A7Q, 5A7S, 5A7W, 5A80 - PubMed Abstract: 
Development of tool molecules that inhibit Jumonji demethylases allows for the investigation of cancer-associated transcription. While scaffolds such as 2,4-pyridinedicarboxylic acid (2,4-PDCA) are potent inhibitors, they exhibit limited selectivity. To discover new inhibitors for the KDM4 demethylases, enzymes overexpressed in several cancers, we docked a library of 600,000 fragments into the high-resolution structure of KDM4A ...